SG Americas Securities, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 87 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10
+400.0%
81,598
+284.4%
0.00%
Q4 2022$2
-100.0%
21,228
-82.1%
0.00%
Q3 2022$18,000
-30.8%
118,918
+303.9%
0.00%
Q2 2022$26,000
-82.4%
29,443
-75.3%
0.00%
-100.0%
Q1 2022$148,000
+87.3%
119,157
+194.5%
0.00%
Q4 2021$79,000
-62.0%
40,460
-46.7%
0.00%
-100.0%
Q3 2021$208,000
+617.2%
75,925
+416.5%
0.00%
Q4 2020$29,00014,7000.00%
Other shareholders

There were no reported owners of VISTAGEN THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of VISTAGEN THERAPEUTICS INC shareholders